alantolactone has been researched along with Thyroid Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Ge, J; Ge, M; Guo, Y; Hu, Y; Li, Q; Liu, Y; Ma, W; Song, F; Wang, J; Wen, Q; Yin, C; Zeng, Q; Zheng, G; Zhu, L | 1 |
1 other study(ies) available for alantolactone and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
Topics: Animals; Apoptosis; Calreticulin; Caspase 3; Caspases; Cell Line, Tumor; Cyclin B1; Cytochromes c; Humans; Mice; Mice, Nude; Mitochondria; Poly(ADP-ribose) Polymerase Inhibitors; Pyroptosis; Reactive Oxygen Species; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2023 |